Gene · 3694
Papers1,301
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,301
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of Integrin Family in Atherosclerotic Cardiovascular Disease: A Prospective Cohort Study and Mendelian Randomization Analysis. | Biomedicines | 2026 | 42652217 | PubTator, text mining | PubMed |
| Integrin β6-Targeted CAR-T Cells exhibit potent antitumor activity in β6-Positive pancreatic ductal adenocarcinoma and lung adenocarcinoma. | Mol Cancer Ther | 2026 | 42594406 | PubTator, text mining | PubMed |
| Tetrandrine-loaded phenylboronic acid-chitosan nanoparticles for enhanced corneal penetration and anti-fibrotic therapy. | Int J Pharm | 2026 | 42567377 | PubTator, text mining | PubMed |
| PF-08046876, a differentiated integrin beta-6 antibody-drug conjugate delivering a potent camptothecin payload optimized for bystander effect and reduced drug efflux. | Mol Cancer Ther | 2026 | 42515977 | PubTator, text mining | PubMed |
| Stanniocalcin 1 promotes gastric cancer progression by activating the PI3K/AKT pathway and inducing M2 macrophage polarization via the JAK2/STAT3/lL-10 axis. | Chin Med J (Engl) | 2026 | 42484012 | PubTator, text mining | PubMed |
| Advances in antibody-drug conjugate-based combination therapy strategies for non-small cell lung cancer. | Expert Opin Biol Ther | 2026 | 42467409 | PubTator, text mining | PubMed |
| Long-term ocular symptoms following COVID-19 linked to immune dysregulation, dysautonomia and peripheral neuropathy. | Nat Commun | 2026 | 42420292 | PubTator, text mining | PubMed |
| Distinct motility and pro-fibrotic effect of renal tubule-derived extracellular vesicles in fibrotic extracellular matrix. | Acta Biomater | 2026 | 42413712 | PubTator, text mining | PubMed |
| LLPS-based classification and a novel prognostic signature reveal NRF1 as a therapeutic target in pancreatic cancer. | Cancer Cell Int | 2026 | 42363116 | PubTator, text mining | PubMed |
| Sex-based differences in tolerability of developmental antibody-drug conjugates (ADCs) in non-small-cell lung cancer (NSCLC). | ESMO Open | 2026 | 42330841 | PubTator, text mining | PubMed |
| Mapping the antibody-drug-conjugates landscape in non-small cell lung cancer: Where are we and where are we going? | Cancer | 2026 | 42226007 | PubTator, text mining | PubMed |
| Spatial transcriptomics of cervical cancer reveals microenvironment shaped the malignant epithelial programs and ECM-associated immune niches. | Cancer Immunol Immunother | 2026 | 42215810 | PubTator, text mining | PubMed |
| Immunohistochemical Evaluation of Integrin β6 Expression in Triple-Negative Breast Cancer as a Predictive Biomarker for Therapeutic and Diagnostic Radionuclides. | Biomolecules | 2026 | 42194054 | PubTator, text mining | PubMed |
| Chronic TGFβ1 Signaling Drives Aberrant Alveolar-Basaloid Metaplasia through a KRT17-Stratifin migratory complex. | bioRxiv | 2026 | 42182417 | PubTator, text mining | PubMed |
| Novel ITGB6 Mutations Causing Amelogenesis Imperfecta. | Genes (Basel) | 2026 | 42074549 | PubTator, text mining | PubMed |
| Identification of COL5A1 and TGFBI as key basement membrane genes and their molecular mechanisms in gestational diabetes mellitus. | Medicine (Baltimore) | 2026 | 42065213 | PubTator, text mining | PubMed |
| Heterogeneity characterization and key pathogenic genes screening based on diabetic nephropathy microenvironment. | Open Life Sci | 2026 | 42037662 | PubTator, text mining | PubMed |
| First-in-Human, Phase I Study of Sigvotatug Vedotin, an Integrin Beta-6-Directed Antibody-Drug Conjugate: Results From Dose Expansion in Advanced Non-Small Cell Lung Cancer. | J Clin Oncol | 2026 | 42008777 | PubTator, text mining | PubMed |
| An Integrin β6-Targeted Antibody-Drug Conjugate Optimized for Intravesical Delivery to Treat Non-Muscle-Invasive Bladder Cancer. | Mol Cancer Ther | 2026 | 42008114 | PubTator, text mining | PubMed |
| Apoptosis induction and migration suppression through regulation of IGF-1R/FoxO signaling pathways in Panc1 pancreatic cancer cells by hAMSCs secretome: An in vitro cell-based therapy. | Cancer Treat Res Commun | 2026 | 41990634 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3694/papers